ATNAHS PHARMA US FDA Approval NDA 017581

NDA 017581

ATNAHS PHARMA US

FDA Drug Application

Application #017581

Documents

Letter2003-05-29
Letter2004-11-16
Letter2007-09-25
Letter2013-03-26
Letter2016-05-11
Label2004-11-16
Label2006-03-14
Label2006-01-25
Label2007-09-26
Label2008-07-29
Letter2004-11-16
Letter2006-03-23
Letter2006-01-30
Letter2007-04-25
Letter2008-07-30
Label2004-11-16
Label2013-03-26
Label2016-05-11
Review2007-04-11
Label2017-03-13
Letter2017-03-14
Letter2019-07-23
Label2019-07-23
Medication Guide2019-07-23
Label2021-04-29
Medication Guide2021-04-29
Letter2021-04-29

Application Sponsors

NDA 017581ATNAHS PHARMA US

Marketing Status

Discontinued002
Discontinued003
Prescription004

Application Products

002TABLET;ORAL250MG1NAPROSYNNAPROXEN
003TABLET;ORAL375MG1NAPROSYNNAPROXEN
004TABLET;ORAL500MG1NAPROSYNNAPROXEN

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1976-03-11STANDARD
LABELING; LabelingSUPPL2AP1976-05-13
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1976-11-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1980-07-15STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1979-05-02STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1979-05-02STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1978-08-04STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1978-11-27STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1979-05-24STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1978-05-02STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1979-06-07STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1979-02-15STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1979-02-15STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1979-07-17STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1979-09-06STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1979-07-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL20AP1979-07-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL24AP1980-04-14STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL26AP1980-03-21STANDARD
LABELING; LabelingSUPPL27AP1980-05-13
LABELING; LabelingSUPPL30AP1980-09-12
LABELING; LabelingSUPPL31AP1982-04-15
LABELING; LabelingSUPPL33AP1981-10-13
LABELING; LabelingSUPPL34AP1981-04-13
MANUF (CMC); Manufacturing (CMC)SUPPL36AP1981-10-13STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL37AP1981-04-02STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL38AP1982-01-08STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL39AP1981-10-13STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL40AP1981-10-13STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL41AP1981-10-13STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL42AP1982-01-07STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL43AP1981-12-21STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL44AP1982-03-31STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL45AP1982-03-31STANDARD
LABELING; LabelingSUPPL46AP1983-09-09
MANUF (CMC); Manufacturing (CMC)SUPPL48AP1983-01-13STANDARD
LABELING; LabelingSUPPL49AP1982-12-03
LABELING; LabelingSUPPL50AP1982-12-03
MANUF (CMC); Manufacturing (CMC)SUPPL51AP1988-02-18STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL53AP1985-04-23STANDARD
LABELING; LabelingSUPPL54AP1983-09-09
MANUF (CMC); Manufacturing (CMC)SUPPL60AP1985-04-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL62AP1985-04-23STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL63AP1986-12-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL64AP1985-04-23STANDARD
EFFICACY; EfficacySUPPL65AP1987-03-23
MANUF (CMC); Manufacturing (CMC)SUPPL67AP1986-07-17STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL68AP1986-06-10STANDARD
LABELING; LabelingSUPPL69AP1985-09-24
LABELING; LabelingSUPPL72AP1986-12-16
EFFICACY; EfficacySUPPL73AP1987-03-23
MANUF (CMC); Manufacturing (CMC)SUPPL80AP1989-04-21STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL86AP1991-10-30STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL87AP1994-04-21STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL88AP1991-09-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL89AP1992-05-08STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL93AP1992-08-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL95AP1994-09-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL96AP1994-03-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL97AP1994-12-08STANDARD
LABELING; LabelingSUPPL98AP2003-04-14STANDARD
LABELING; LabelingSUPPL99AP2004-11-10STANDARD
LABELING; LabelingSUPPL100AP2004-11-10STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL101AP2000-12-08STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL102AP2001-11-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL103AP2002-02-22STANDARD
LABELING; LabelingSUPPL105AP2006-03-10STANDARD
LABELING; LabelingSUPPL106AP2006-01-24STANDARD
LABELING; LabelingSUPPL107AP2007-04-19STANDARD
LABELING; LabelingSUPPL108AP2007-09-20STANDARD
LABELING; LabelingSUPPL110AP2008-07-25STANDARD
LABELING; LabelingSUPPL111AP2013-03-22STANDARD
LABELING; LabelingSUPPL112AP2016-05-09STANDARD
LABELING; LabelingSUPPL113AP2017-03-10STANDARD
LABELING; LabelingSUPPL114AP2019-07-22STANDARD
LABELING; LabelingSUPPL115AP2021-04-28STANDARD

Submissions Property Types

SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL9Null0
SUPPL10Null0
SUPPL11Null0
SUPPL12Null0
SUPPL13Null0
SUPPL15Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0
SUPPL24Null0
SUPPL26Null0
SUPPL36Null0
SUPPL37Null0
SUPPL38Null0
SUPPL39Null0
SUPPL40Null0
SUPPL41Null0
SUPPL42Null0
SUPPL43Null0
SUPPL44Null0
SUPPL45Null0
SUPPL48Null0
SUPPL51Null0
SUPPL53Null0
SUPPL60Null0
SUPPL62Null0
SUPPL63Null0
SUPPL64Null0
SUPPL67Null0
SUPPL68Null0
SUPPL80Null0
SUPPL86Null0
SUPPL87Null0
SUPPL88Null0
SUPPL89Null0
SUPPL93Null0
SUPPL95Null0
SUPPL96Null0
SUPPL97Null0
SUPPL101Null0
SUPPL102Null0
SUPPL103Null0
SUPPL111Null15
SUPPL112Null15
SUPPL113Null6
SUPPL114Null7
SUPPL115Null7

TE Codes

004PrescriptionAB

CDER Filings

ATNAHS PHARMA US
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 17581
            [companyName] => ATNAHS PHARMA US
            [docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/017581s115,018164s065,020067s064lbl.pdf#page=23"]
            [products] => [{"drugName":"NAPROSYN","activeIngredients":"NAPROXEN","strength":"250MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"NAPROSYN","activeIngredients":"NAPROXEN","strength":"375MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"NAPROSYN","activeIngredients":"NAPROXEN","strength":"500MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"04\/28\/2021","submission":"SUPPL-115","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/017581s115,018164s065,020067s064lbl.pdf\"}]","notes":""},{"actionDate":"07\/22\/2019","submission":"SUPPL-114","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/017581s114,018164s064,020067s021lbl.pdf\"}]","notes":""},{"actionDate":"03\/10\/2017","submission":"SUPPL-113","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/017581s113,018164s063,020067s020lbl.pdf\"}]","notes":""},{"actionDate":"05\/09\/2016","submission":"SUPPL-112","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/017581s112,018164s062,020067s019lbl.pdf\"}]","notes":""},{"actionDate":"05\/09\/2016","submission":"SUPPL-112","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/017581s112,018164s062,020067s019lbl.pdf\"}]","notes":""},{"actionDate":"03\/22\/2013","submission":"SUPPL-111","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/017581s111,018164s061,018965s020,020067s018lbl.pdf\"}]","notes":""},{"actionDate":"07\/25\/2008","submission":"SUPPL-110","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/017581s110,18164s60,18965s18,20067s17lbl.pdf\"}]","notes":""},{"actionDate":"09\/20\/2007","submission":"SUPPL-108","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/017581s108,18164s58,18965s16,20067s14lbl.pdf\"}]","notes":""},{"actionDate":"03\/10\/2006","submission":"SUPPL-105","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"\"}]","notes":""},{"actionDate":"01\/24\/2006","submission":"SUPPL-106","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/017581s106,018164s056,018965s014,020067s011lbl.pdf\"}]","notes":""},{"actionDate":"11\/10\/2004","submission":"SUPPL-100","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2004\\\/17581s99,100,18164s50,51,18965s9,10,20067s4,6lbl.pdf\"}]","notes":""},{"actionDate":"11\/10\/2004","submission":"SUPPL-99","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2004\\\/17581s99,100,18164s50,51,18965s9,10,20067s4,6lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"NAPROSYN","submission":"NAPROXEN","actionType":"250MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"NAPROSYN","submission":"NAPROXEN","actionType":"375MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"NAPROSYN","submission":"NAPROXEN","actionType":"500MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2021-04-28
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.